AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)
$33.01 0.09 (0.2734%)
Analysed AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) News Sources
Alpha Thalassemia (US, EU4, UK, and Japan) Market Insights, Epidemiology, and Forecasts 2022-2025 & 2025-2036
13-04-2026
yahoo.com
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
06-04-2026
yahoo.com
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
01-04-2026
yahoo.com
A Look At Agios Pharmaceuticals (AGIO) Valuation After Recent Share Price Momentum
01-04-2026
yahoo.com
Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?
01-04-2026
yahoo.com
Agios Rallies On A Surprise FDA Move In Sickle Cell, Pulling Rival Fulcrum Higher
31-03-2026
yahoo.com
Sector Update: Health Care Stocks Higher Late Afternoon
31-03-2026
yahoo.com
Sector Update: Health Care Stocks Higher Tuesday Afternoon
31-03-2026
yahoo.com
Why Agios Pharmaceuticals Stock Is Up More Than 21% Today
31-03-2026
fool.com
Insider Sells AGIO Shares Worth $82,000 -- But Context Is Everything
31-03-2026
fool.com
What is the current price of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)?
The current price of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) is $33.01.
AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) since the previous trading day is $0.09.
AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) since the previous trading day is 0.2734%.
What is the most recent average sentiment score for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)?
The most recent average sentiment score for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)?
The most recent sentiment for AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ) is .
SEC-8K** Filing Available For AGIOS PHARMACEUTICALS INC (AGIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.